Intuitive Surgical, US46120E6023

Intuitive Surgical stock steadies on a Q2 beat

Published on 09/03/2026 at 17:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock steadies after Q2 2026 revenue of USD 2.89 billion and EPS of USD 2.80. The latest MarketBeat snapshot also shows a market cap above USD 131 billion and a 52-week range from USD 328.57 to USD 603.88.

Extreme Makrofotografie einer miniaturisierten chirurgischen Roboterarmspitze mit Nadelhalter-Handgelenk, feinen Kabelzügen und präzisionsgefrästen Titangelenken, flache Schärfentiefe, metallisch-blaue Töne
Intuitive Surgical US46120E6023 Makroaufnahme zeigt miniaturisierten Roboter Endeffektor mit präziser feiner Gelenkmechanik, Illustration mit AI erstellt.

Intuitive Surgical (US46120E6023) stock traded at USD 371.88 and carries a market value of USD 131.38 billion, while the latest quarter delivered revenue of USD 2.89 billion and EPS of USD 2.80. MarketBeat and a recent ad hoc update both point to the same Q2 2026 setup, with the stock still well below its 52-week high of USD 603.88.

Q2 2026 beat

According to MarketBeat, the company posted USD 2.80 in quarterly EPS, topping the USD 2.48 estimate by USD 0.32, while revenue of USD 2.89 billion came in above USD 2.83 billion in estimates. Revenue was up 18.4 percent year over year, and net margin stood at 28.45 percent.

The same source says analysts still assign a Moderate Buy consensus and an average price target of USD 508.68. That is 36.9 percent above the USD 371.88 trading level cited in the same snapshot.

Procedure growth cools

A recent ad hoc update said worldwide da Vinci procedure growth was guided at about 13 percent to 15 percent for 2026, below the 18 percent pace in 2025. It also cited Q2 2026 earnings of USD 818.1 million, equal to a margin of 28.29 percent for the period ended June 30, 2026.

That combination matters for investors because system placements, installed base growth and recurring instruments sales still support the model, but procedure growth is no longer accelerating at last year s pace. The same update said 468 da Vinci systems were placed in Q2 2026, up from 395 a year earlier, and the installed base reached 11,710 systems on June 30, 2026.

Go deeper

More on Intuitive Surgical stock and fundamentals

The dedicated topic page collects the latest company news, market data and filing context for Intuitive Surgical.

da Vinci stays central

The core product remains the da Vinci robotic surgery platform, with the latest generation designed to support minimally invasive procedures in hospitals and surgical centers. Market estimates cited in the ad hoc update put a da Vinci 5 system at about USD 1.8 million to USD 2.5 million, which underscores why each placement can carry a long recurring-revenue tail.

Stock near the low end

Intuitive Surgical stock closed at USD 371.88 on September 3, 2026, with a 12-month low of USD 328.57 and a 12-month high of USD 603.88. The market capitalization was USD 131.38 billion in the same snapshot, leaving the shares closer to the lower end of their range than to the peak.

Key data for Intuitive Surgical

  • Company: Intuitive Surgical Inc.
  • ISIN: US46120E6023
  • Ticker: ISRG
  • Trading venue: NASDAQ
  • Price (as of September 3, 2026): USD 371.88
  • Market capitalization: USD 131.38 billion (as of September 3, 2026)
  • Sector / Industry: Health Care / Medical Instruments
  • Index membership: S&P 500

Follow Intuitive Surgical stock on social media

Disclaimer...

en | US46120E6023 | INTUITIVE SURGICAL | boerse | 70049858 | bgmi